Comparing Nd:YAG Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy

August 24, 2018 updated by: Weerawat Kiddee, Prince of Songkla University

Randomized Clinical Trial Comparing Neodynium:Ytrium-aluminium-garnet (Nd:YAG) Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy in Patients With Dark Iris

No single type of laser or set of laser parameters is appropriate for all type of irides. Pure Nd:YAG laser iridotomy is very effective in the light color irides. It was considered as the gold standard for iridotomy. It, however, is less effective and causes some complication such as iris hemorrhage especially in patients with dark iris.

Study Overview

Detailed Description

By using the double frequency YAG to make the initial bore and the Nd:YAG laser to complete the perforation, the technique should be able to effectively combine most of the advantages of both lasers whilst avoiding their disadvantages. It is possibly the ideal iridotomy technique to use in the Asian irides. The investigators aim to study the energy use for laser iridotomy comparing between the two techniques as well as objectively measure the variables associated with complications.

Study Type

Interventional

Enrollment (Actual)

82

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Songkhla
      • Hat Yai, Songkhla, Thailand, 90110
        • Weerawat Kiddee

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient in need to have a laser iridotomy

    • primary angle closure glaucoma or
    • primary angle closure or
    • primary angle closure suspect (needed repeated pupil dilation) or
    • fellow eyes of acute angle closure crisis, and
  • Age of at least 18 years, and
  • Dark iris patients (only black and dark brown color)

Exclusion Criteria:

  • Eye with acute angle closure crisis
  • Active conjunctiva or corneal infection or inflammation
  • Active anterior uveitis
  • History of any prior laser treatment
  • History intraocular surgery
  • Eye with corneal scar
  • Corneal haziness obscure iridotomy site
  • Endothelial cell count less than 1000 cells/mm2 (pre-laser)
  • Iris color other than black or dark brown
  • Inability to sit at the slit lamp to have laser done

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The sequential technique
By using the double frequency YAG laser to make the initial bore and the Nd:YAG laser to complete the perforation on iris.
By using 'the double frequency YAG laser' to make the initial bore and 'the Nd:YAG laser' to complete the perforation on iris.
Active Comparator: The pure Nd:YAG laser technique
By using the pure Nd:YAG to make a complete perforation on iris.
By using 'the pure Nd:YAG laser' to make a complete perforation on iris.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Laser energy
Time Frame: 1-hour
Total energy used to create patency on the iris
1-hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bleeding
Time Frame: 1-hour
iris bleeding immediate after laser reported as Yes or No
1-hour
Corneal endothelial cell count
Time Frame: 12-month
Corneal endothelial cell count directly over the area of laser
12-month
Central corneal thickness
Time Frame: 12-month
Central corneal thickness
12-month
Patency of iridotomy
Time Frame: 12-month
Iridotomy patency is confirmed objectively reported as yes or no
12-month
Intraocular pressure spike
Time Frame: 1-hour
Intraocular pressure spike if present mean that IOP evelation of at least 8mmHg from baseline intraocular pressure
1-hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Asst.Prof.Weerawat Kiddee, MD, Prince of Songkla University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (Actual)

August 1, 2018

Study Completion (Actual)

August 1, 2018

Study Registration Dates

First Submitted

June 11, 2015

First Submitted That Met QC Criteria

June 12, 2015

First Posted (Estimate)

June 17, 2015

Study Record Updates

Last Update Posted (Actual)

August 27, 2018

Last Update Submitted That Met QC Criteria

August 24, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • EC-58-093-02-1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Angle Closure Glaucoma

Clinical Trials on The sequential technique

Subscribe